Literature DB >> 9496893

Tumor oxygenation after mild-temperature hyperthermia in combination with carbogen breathing: dependence on heat dose and tumor type.

K Okajima1, R J Griffin, K Iwata, A Shakil, C W Song.   

Abstract

We investigated the effect of hyperthermia at 40.5-42.5 degrees C as well as the combination of hyperthermia and carbogen breathing on oxygenation in the SCK murine mammary carcinoma. In addition, the important question of how long the effect of heating on tumor oxygenation lasts was addressed in both SCK and FSaII (murine fibrosarcoma) tumors. The median pO2 in control SCK tumors was 4.4 +/- 0.2 mm Hg, and it increased to a maximum of 12.6 +/- 1.2 mm Hg when the tumors were heated at 41.5 degrees C for 1 h. Carbogen breathing increased the median pO2 of SCK tumors to 17.1 +/- 1.4 mm Hg, but after heating at 41.5 degrees C, it elevated the pO2 in SCK tumors markedly to 31.3 +/- 4.2 mm Hg. The kinetics of the return to baseline oxygenation after hyperthermia was found to vary with the type of tumor and the heat dose. The pO2 of FSaII tumors remained significantly higher than that of control tumors 24 h after heating at 41.5 degrees C for 60 min. The pO2 of SCK tumors remained elevated for up to 3 h after heating at 41.5 degrees C for 30 min, but if the tumors were heated for 60 min at this temperature, the median oxygen tension declined to the control level within 1 h after heating. It was concluded that mild-temperature hyperthermia, i.e. 41.5 degrees C, alone and in combination with carbogen breathing dramatically improves the oxygenation of these murine tumors and that the tumor type influences the duration of changes in oxygenation induced by mild-temperature hyperthermia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9496893

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  9 in total

1.  Kadota Fund International Forum 2004. Application of thermal stress for the improvement of health, 15-18 June 2004, Awaji Yumebutai International Conference Center, Awaji Island, Hyogo, Japan. Final report.

Authors:  Tsutomu Sugahara; J van der Zee; Harm H Kampinga; Zeliko Vujaskovic; Motoharu Kondo; Takeo Ohnishi; Gloria Li; Heon J Park; Dennis B Leeper; Valentina Ostapenko; Elizabeth A Repasky; Masami Watanabe; Chang W Song
Journal:  Int J Hyperthermia       Date:  2008-03       Impact factor: 3.914

2.  Commentary on classic paper in hyperthermic oncology 'Tumour oxygenation is increased by hyperthermia at mild temperatures' by CW Song et al., 1996.

Authors:  Robert J Griffin; Peter M Corry
Journal:  Int J Hyperthermia       Date:  2009-03       Impact factor: 3.914

Review 3.  Hypoxia-driven immunosuppression: a new reason to use thermal therapy in the treatment of cancer?

Authors:  Chen-Ting Lee; Thomas Mace; Elizabeth A Repasky
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

4.  Tumour thermotolerance, a physiological phenomenon involving vessel normalisation.

Authors:  Ruud P M Dings; Melissa L Loren; Yan Zhang; Sterling Mikkelson; Kevin H Mayo; Peter Corry; Robert J Griffin
Journal:  Int J Hyperthermia       Date:  2011-01-04       Impact factor: 3.914

Review 5.  Mild temperature hyperthermia and radiation therapy: role of tumour vascular thermotolerance and relevant physiological factors.

Authors:  Robert J Griffin; Ruud P M Dings; Azemat Jamshidi-Parsian; Chang W Song
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

6.  Changes in tumor hypoxia induced by mild temperature hyperthermia as assessed by dual-tracer immunohistochemistry.

Authors:  Xiaorong Sun; Xiao-Feng Li; James Russell; Ligang Xing; Muneyasu Urano; Gloria C Li; John L Humm; C Clifton Ling
Journal:  Radiother Oncol       Date:  2008-06-05       Impact factor: 6.280

Review 7.  Accurate Three-Dimensional Thermal Dosimetry and Assessment of Physiologic Response Are Essential for Optimizing Thermoradiotherapy.

Authors:  Mark W Dewhirst; James R Oleson; John Kirkpatrick; Timothy W Secomb
Journal:  Cancers (Basel)       Date:  2022-03-27       Impact factor: 6.639

8.  Upconverting nanoparticle-containing erythrocyte-sized hemoglobin microgels that generate heat, oxygen and reactive oxygen species for suppressing hypoxic tumors.

Authors:  Hanju Kim; Johyun Yoon; Hwang Kyung Kim; Woo Tak Lee; Nguyen Thi Nguyen; Xuan Thien Le; Eun-Hee Lee; Eun Seong Lee; Kyung Taek Oh; Han-Gon Choi; Yu Seok Youn
Journal:  Bioact Mater       Date:  2022-09-28

9.  Combined Antitumor Therapy Using In Situ Injectable Hydrogels Formulated with Albumin Nanoparticles Containing Indocyanine Green, Chlorin e6, and Perfluorocarbon in Hypoxic Tumors.

Authors:  Woo Tak Lee; Johyun Yoon; Sung Soo Kim; Hanju Kim; Nguyen Thi Nguyen; Xuan Thien Le; Eun Seong Lee; Kyung Taek Oh; Han-Gon Choi; Yu Seok Youn
Journal:  Pharmaceutics       Date:  2022-01-08       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.